ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,698.80
      -2.09%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.11
      0.07%
      Bitcoin
      57,249.74
      -0.88%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aerpio Pharmaceuticals Inc (ARPO)

      7. Aerpio Pharmaceuticals Inc (ARPO) News

      ARPO

      Aerpio Pharmaceuticals (ARPO)

      Aerpio Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ARPO
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      04/02/20185:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      03/23/20186:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      03/21/20184:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      03/15/20185:09PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      03/13/20188:22AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      02/21/20189:17AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      02/14/20186:09PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      02/14/20186:07PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      01/08/20189:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      12/18/20175:18PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      12/18/20175:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      12/18/20175:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      12/18/20175:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      12/18/20175:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      12/06/20179:46AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      11/16/20174:52PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      11/14/20175:19PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      11/14/20174:55PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      11/13/201711:06AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      11/13/20179:29AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARPOAerpio Pharmaceuticals Inc
      10/10/20179:19AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ARPOAerpio Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:ARPO